Purdue Pharma has gained support from attorneys general in 55 U.S. states and territories for a $7.4 billion settlement aimed at resolving thousands of lawsuits related to the opioid crisis. The deal, announced Monday, includes $6.5 billion from members of the Sackler family, who own the company, and $900 million from Purdue itself. The settlement is to resolve claims that Purdue Pharma’s pain medication, OxyContin, caused an opioid addiction crisis in the U.S. More than 850,000 people have died from opioid-related overdoses in the U.S. since 1999, according to the Centers for Disease Control and Prevention. Purdue Pharma’s drug OxyContin was at the center of the first wave of overdose deaths in the early 2000s. MORE: https://www.wthr.com/article/news/nation-world/purdue-pharma-opioid-settlement/507-61e6a125-01f3-4cbe-bdcf-6b068ebfb513